The advancements in chemical and pharmaceutical technology over the past decade have introduced some new players into the ever-expanding market of weight loss and Alli is one of the market leaders.
The chemical capsule is produced by GlaxoSmithKline, the world’s largest pharmaceutical company, and is sold as a weight loss treatment. We will find out if it is effective or if indeed it is a waste of money.
The obesity epidemic is sweeping through America and Europe and this gives rise for a need to control it. GlaxoSmithKline believe that they have found the answer by way of a pill that can absorb fat from the human diet and therefore prevent weight gain.
The product claims that there have been trials on multiple subjects and that almost half of them lost 5% body fat as a result of a using this product for a year. Around one fifth of subjects lost 10% body fat in the years trial.
So does this indicate success? Unfortunetely not. The trial shows that over half of the subjects failed to lose at least 5% body fat and therefore where not much better off than they were previously. Alli also causes some quite irritating side effects such as an increase in bowel movements and increased perspiration. As a result, there are several conditions under which this product is advised to be avoided such as during pregnancy and after recovering from illnesses.
GlaxoSmithKline market this product with some trial research that details figures about the reduction in subjects contracting type 2 diabetes whilst taking Alli. They also mention that Alli will also reduce blood pressure of users and so maybe this product can be put to good use in cases of obesity.
The product is recommended for sale to only those over the age of 18 and with a body mass index score of over 28. People that fall into this category are categorised as morbidly obese and therefore are very unlikely to be able to walk or do any form of exercise.
Alli is an over the counter version of Xenical and costs $39.50 for 42 pills and $65.00 for 84. The recommended dosage is to consume 4 capsules a day following meal times and prior to sleeping.
GlaxoSmithKline are a worldwide brand and possibly one of the most trusted brand names in the medicine industry. This product has huge backing and belief by the company to release it. They believe that it has the ability to change the lives of those people that are perhaps bed bound through obesity or unable to walk or do any exercise.
They do make it clear that Alli is not an alternative to healthy eating, more of an aide to be used conjunction with a good nutritional plan.
The active ingredient in Alli is Orlistat, which is a substance that is also found in other weight loss dieting pills but none to the quantity that Alli does. Orlistat accounts for approximately 50% of the pill making Alli the highest concentrated active ingredient pill.
As mentioned, the active ingredient will essentially prevent the stomach from digesting the fats into the walls of the stomach and therefore reduces the rate at which fat is created and stored on the body. However for best results the pill intake should be accompanied by a healthy eating plan. Ironically, eating healthy foods will help you lose weight all by itself, questioning the need to use Alli at all.
Does Alli Really Aid Weight Loss??
Clinical tests have shown that half of subjects lost 5% or more body fat after a year on constant use. This does not take into account the subject’s nutritional plans and exercise regime. The general consensus is that the best way to lose weight is to perform consistent exercise.
The Alli pill is a lazy way to lose weight and the evidence is not conclusive. For obese people that have type-2 diabetes or high blood pressure, this pill is likely to stimulate fat loss as well as improve medical condition.
Alli can help you lose weight but should always be a last alternative. Healthy eating and exercise are far better methods of fat loss but Alli does offer some benefits. However, it must be used as per the instructions and a healthy eating plan is essential for best results.